Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guérin through Toll-like receptor signalling

BJU International

Volumn 97, Issue 4, 2006, Pages 860-864

  Miyazaki, Jun ^a   Kawai, Koji ^a   Oikawa, Takehiro ^a   Johraku, Akira ^a   Hattori, Kazunori ^a   Shimazui, Toru ^a   Akaza, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

BCG; Mycobacterium bovis; Toll like receptor; Urinary cytokine; Uroepithelial cells

Indexed keywords

BCG VACCINE; CD14 ANTIGEN; COMPLEMENTARY DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MD 2; RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLADDER EPITHELIUM; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; KERATINOCYTE; MOLECULAR PROBE; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME SERIES ANALYSIS; UROTHELIUM;

ANIMALS; BCG VACCINE; CATTLE; CELL LINE; EPITHELIAL CELLS; HUMANS; MYCOBACTERIUM BOVIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUBERCULOSIS, BOVINE; URINARY TRACT INFECTIONS;

EID: 33644882498     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06026.x     Document Type: Article

References (30)

1. Akaza H Hinotsu S Aso Y Kakizoe T Koiso K Bacillus Calmette-Guerin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results. The Bladder Cancer BCG Study Group Cancer 1995 75 552 9
2. Martinez-Pineiro JA Jimenez Leon J Martinez-Pineiro L et al. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer J Urol 1990 143 502 6
3. Lamm DL Complications of bacillus Calmette-Guerin immunotherapy Urol Clin North Am 1992 19 565 72
4. Akaza H New strategy of bio-chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrence Gan To Kagaku Ryoho 1997 24 Suppl. 1 253 6
5. de Reijke TM de Boer EC Kurth KH Schamhart DH Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value J Urol 1996 155 477 82
6. Ratliff TL Role of the immune response in BCG for bladder cancer Eur Urol 1992 21 Suppl. 2 17 21
7. Tsuji S Matsumoto M Takeuchi O et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors Infect Immun 2000 68 6883 90
8. de Reijke TM Vos PC de Boer EC et al. Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG) Urol Res 1993 21 349 52
9. Chen F Zhang G Iwamoto Y See WA Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking alpha 5 beta 1 integrin J Urol 2003 170 605 10
10. Ikeda N Toida I Iwasaki A Kawai K Akaza H Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guerin (BCG): a role of BCG internalization into tumor cells Int J Urol 2002 9 29 35
11. Kawamata H Hattori K Omotehara F et al. Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor Int J Oncol 1999 15 661 7
12. Asai Y Jinno T Ogawa T Oral treponemes and their outer membrane extracts activate human gingival epithelial cells through toll-like receptor 2 Infect Immun 2003 71 717 25
13. Liu S Gallo DJ Green AM et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide Infect Immun 2002 70 3433 42
14. Backhed F Soderhall M Ekman P Normark S Richter-Dahlfors A Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract Cell Microbiol 2001 3 153 8
15. Takeshita F Leifer CA Gursel I et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells J Immunol 2001 167 3555 8
16. Yamamoto S Kuramoto E Shimada S Tokunaga T In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG Jpn J Cancer Res 1988 79 866 73
17. Hemmi H Takeuchi O Kawai T et al. A Toll-like receptor recognizes bacterial DNA Nature 2000 408 740 5
18. Yang H Young DW Gusovsky F Chow JC Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1 J Biol Chem 2000 275 20861 6
19. Samuelsson P Hang L Wullt B Irjala H Svanborg C Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa Infect Immun 2004 72 3179 86
20. Akira S Takeda K Kaisho T Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2001 2 675 80
21. Takeda K Kaisho T Akira S Toll-like receptors Annu Rev Immunol 2003 21 335 76
22. Svanborg C Godaly G Hedlund M Cytokine responses during mucosal infections: role in disease pathogenesis and host defence Curr Opin Microbiol 1999 2 99 105
23. Olszyna DP Opal SM Prins JM et al. Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis J Infect Dis 2000 182 1731 7
24. Schilling JD Martin SM Hung CS Lorenz RG Hultgren SJ Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli Proc Natl Acad Sci USA 2003 100 4203 8
25. Nadler R Luo Y Zhao W et al. Interleukin 10 induced augmentation of delayed- type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guerin (BCG) mediated antitumour activity Clin Exp Immunol 2003 131 206 16
26. Diehl S Rincon M The two faces of IL-6 on Th1/Th2 differentiation Mol Immunol 2002 39 531 6
27. de Boer EC Somogyi L de Ruiter GJ de Reijke TM Kurth KH Schamhart DH Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer Urol Res 1997 25 31 4
28. Saint F Patard JJ Irani J et al. Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer Urology 2001 57 617 22
29. O'Neill LA Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases Curr Opin Pharmacol 2003 3 396 403
30. Bochud PY Hawn TR Aderem A Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling J Immunol 2003 170 3451 4